Humana ( (HUM) ) has released its Q4 earnings. Here is a breakdown of the information Humana presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Humana Inc., a leading health and wellbeing company, focuses on providing various insurance and health care services, particularly in Medicare and Medicaid sectors, aiming to enhance overall healthcare experiences. Humana reported a challenging fourth quarter of 2024, with a net loss per share of $5.76 on a GAAP basis, partially offsetting a robust full-year 2024 performance. Despite a challenging quarter, Humana recorded full-year earnings per share of $9.98 on a GAAP basis and $16.21 on an adjusted basis, showcasing overall resilience. The company maintained its forward guidance for 2025, with expectations for GAAP EPS of approximately $15.88 and adjusted EPS of $16.25, amidst strategic realignments including exiting certain unprofitable Medicare Advantage plans. Key financial metrics highlighted a decline in Medicare Advantage membership and increased benefit expense ratios due to elevated medical cost trends, which were partly mitigated by operational efficiencies and value creation initiatives. Management remains optimistic about long-term strategic initiatives, including advancements in Medicaid and CenterWell strategies, expected to enhance earnings over the mid to long term.
